pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 1,486 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 2
AAVB-039
Juvenile Macular Degeneration (Stargardt Disease)
AAVantgarde Bio Srl
0 catalysts
Phase 2
AB-001
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Artbio Inc
0 catalysts
Phase 2
AB-002
Thrombosis
Lysyl oxidase homolog 2
Aronora Inc
0 catalysts
Phase 2
← prev
page 3 of 50
next →
131
Pain89
Neurology1
AB-1003
Limb-Girdle Muscular Dystrophy
Asklepios BioPharmaceutical Inc
0 catalysts
Phase 2
AB-1009
Pompe Disease
Asklepios BioPharmaceutical Inc
0 catalysts
Phase 2
AB-2100
Metastatic Renal Cell Carcinoma
Arsenal Biosciences Inc
0 catalysts
Phase 2
ABBVCLS-628
Polycystic Kidney Disease
Calico Life Sciences LLC
0 catalysts
Phase 2
ABI-110
Polypoidal Choroidal Vasculopathy
Avirmax Inc
0 catalysts
Phase 2
ABO-101
Primary Hyperoxaluria Type I
Chiesi Farmaceutici SpA
0 catalysts
Phase 2
ABP-745
Gouty Arthritis (Gout)
Atom Therapeutics Co Ltd
0 catalysts
Phase 2
ABS-201
Androgenic Alopecia
Almirall SA
0 catalysts
Phase 2
ABSK-141
Solid Tumor
Abbisko Therapeutics Co Ltd
0 catalysts
Phase 2
ACD-440
Neuropathic Pain (Neuralgia)
AlzeCure Pharma AB
0 catalysts
Phase 2
ACDN-01
Juvenile Macular Degeneration (Stargardt Disease)
Ascidian Therapeutics Inc
0 catalysts
Phase 2
ACE-1831
Immunoglobulin G4-Related Disease (IgG4-RD)
Acepodia Inc
0 catalysts
Phase 2
ACI-24060
Alzheimer's Disease
$ACIUAC Immune SA
0 catalysts
Phase 2
ACP-01
Vescell
Chronic Stable Angina
Hemostemix Inc
0 catalysts
Phase 2
ACP-017
Cutaneous Squamous Cell Carcinoma (cSCC)
Ascendis Pharma AS
0 catalysts
Phase 2
ACT-001
Pediatric Diffuse Intrinsic Pontine Glioma
Accendatech Co Ltd
0 catalysts
Phase 2
ACTX-401
Spinal Muscular Atrophy (SMA)
Alcyone Therapeutics Inc
0 catalysts
Phase 2
ADCED-01
Soft Tissue Sarcoma
ADCendo ApS
0 catalysts
Phase 2
ADG-116
Solid Tumor
$ADAGAdagene Inc.
0 catalysts
Phase 2
AFM-24I
Breast Cancer
Affimed GmbH
0 catalysts
Phase 2
AFTX-201
Dilated Cardiomyopathy
Affinia Therapeutics Inc
0 catalysts
Phase 2
AGA-2115
Osteogenesis Imperfecta
Angitia Biopharmaceuticals Ltd
0 catalysts
Phase 2
AGLE-102
Burns
Aegle Therapeutics Corp
0 catalysts
Phase 2
AGT-100216
Charcot-Marie-Tooth Disease Type I A
Augustine Therapeutics NV
0 catalysts
Phase 2
AGuIX
Glioblastoma Multiforme (GBM)
NH TherAguix SAS
0 catalysts
Phase 2
AI-081
Solid Tumor
OncoC4 Inc
0 catalysts
Phase 2
AION-301
Chronic Kidney Disease (Chronic Renal Failure)
AION Healthspan Inc
0 catalysts